In addition to their medical implications, these skin manifestations can be a source of patient distress as a result of symptomatology and cosmesis.
This article provides a framework for interpreting paired Ross River virus and Barmah Forest virus serology results in an environment where numerical antibody titres are not routinely provided.
Primary prevention is the prompt antibiotic treatment of Strep A infection, and it can reduce the risk of developing acute rheumatic fever and rheumatic heart disease.
Clinic managers are encouraged to review their follow-up and electronic reminder systems, as these are associated with benefits for clients who require secondary prophylaxis for acute rheumatic fever.
This issue focuses on rheumatology and includes articles on acute rheumatic fever, rheumatoid arthritis and the role of exercise in management of rheumatological disease.
Successful implementation of evidence-based medicine requires framing within the cultural and structural barriers Aboriginal and Torres Strait Islander people experience.
Scabies, an under-appreciated global health concern, needs to be considered in the differential of any pruritic cutaneous dermatoses.
The usefulness of modern point-of-care tests for group A streptococci (GAS) is determined by the presence of carriers of GAS.
This case study discusses the differential diagnoses and appropriate tests and investigations for a man aged 32 years with bilateral optic disc swelling.
Micro-level actions by primary care staff can have a valuable and immediate impact on the healthcare experiences of Aboriginal and Torres Strait Islander people.
A case presentation of lower limb rash with purpura below the knee.
Strategies to improve the implementation of muscle health assessment and management in general practice.
This issue explores ‘old’ infectious diseases (scabies, syphilis), ‘new’ infectious diseases (CJD, COVID-19), and medical advances such as RSV prevention products and point-of-care testing.
This study evaluates the susceptibility pattern of Neisseria gonorrhoeae to cefixime, ceftriaxone, azithromycin and doxycycline.